CAR-T cell manufacturing: time to put it in gear-Reference-Cited by-同舟云学术

CAR-T cell manufacturing: time to put it in gear

Published:2017-04-20 Issue:5 Volume:57 Page:1104-1106
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:EDITORIAL

Author:

Bersenev Alexey¹

Affiliation:

1. Advanced Cell Therapy Laboratory; Yale-New Haven Hospital, Yale University; New Haven CT

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14110/fullpdf

Reference11 articles.

1. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N Engl J Med,2011

2. 2012 https://www.pennmedicine.org/news/news-releases/2012/august/university-of-pennsylvania-and

3. Grupp S Laetsch T Buechner J 2016

4. 2016

5. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia;Porter;Sci Transl Med,2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy;Expert Review of Clinical Immunology;2024-05-14

2. Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel;Transfusion;2024-02-28

3. The Science of CAR ‐T Cell Technology;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation;Frontiers in Immunology;2024-01-12

5. Cellular Therapies for Cancer: Chimeric Antigen Receptor T Cells (CAR-T);The Basics of Cancer Immunotherapy;2024